RGNX ▼ -2.5% - REGENXBIO Inc. $RGNX RGNX - REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting 24-SEP-2026 07:19 PM ET